September 2006. Volume 2. Number 3

Exposure to angiotensin-converting–enzyme inhibitors should be avoided during the first trimester of pregnancy

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Cooper WO, Hernández-Díaz S, Arbogast PG, Dudley JA, Dyer S, Gildeon PS, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354:2443-51
Reviewers: González de Dios J1, Perdikidis Olivieri L2.
1Departamento de Pediatrí­a. Hospital General Universitario de Alicante. España.
2 EAP Los Fresnos. Torrejón de Ardoz. Área III. Madrid. España.
Correspondence: Javier González de Dios. Email: javier.gonzalezdedios@gmail.com
Reception date: 20/07/2006
Acceptance date: 22/07/2006
Publication date: 01/09/2006

Abstract

How to cite this article

González de Dios J, Perdikidis Olivieri L. Es prudente evitar el uso de inhibidores de la enzima convertidora de la angiotensina como tratamiento antihipertensivo en el primer trimestre de la gestación. Evid Pediatr. 2006;2:45.

AVC | Critically appraised articles

Cooper WO, Hernández-Díaz S, Arbogast PG, Dudley JA, Dyer S, Gildeon PS, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354:2443-51
Reviewers: González de Dios J1, Perdikidis Olivieri L2.
1Departamento de Pediatrí­a. Hospital General Universitario de Alicante. España.
2 EAP Los Fresnos. Torrejón de Ardoz. Área III. Madrid. España.
Correspondence: Javier González de Dios. Email: javier.gonzalezdedios@gmail.com
Reception date: 20/07/2006
Acceptance date: 22/07/2006
Publication date: 01/09/2006

How to cite this article

González de Dios J, Perdikidis Olivieri L. Es prudente evitar el uso de inhibidores de la enzima convertidora de la angiotensina como tratamiento antihipertensivo en el primer trimestre de la gestación. Evid Pediatr. 2006;2:45.

References

  1. Quan A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and antiotensin receptor antagonists. Early Human Dev. 2006;82:23-8.
  2. Levine M, Walter S, Lee H, Haines T. User´s guide to the medical literatura. IV. How to use an article about harm. JAMA. 1994;271:1615-9.
  3. Friedman JM. AC inhibitors and congenital anomalies. N Engl J Med. 2006;354;2498-500.
  4. Sackett Dl, Richardson WS, Rosenberg W, Haynes RB. Medicina basada en la evidencia. Cómo ejercer y enseñar la MBE. Madrid: Churchill Livingstone;1997.
  5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. Hypertension. 2003;42:1206-52.
01/09/2006

Linked Comment